Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of ganciclovir during continuous renal replacement therapy
2007-002069-11Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Jun 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ganciclovir in cytomegalovirus disease (CMV), sponsored by Medical University of Vienna. Primary endpoint: Pharmacokinetic parameters of ganciclovir. Started Jun 2008; status: completed.
02
Drugs
ganciclovir
03
Conditions
cytomegalovirus disease (CMV)
Beyond the preview
Go deeper on 2007-002069-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002069-11.